Parallel Advisors »

Neurogene shares owned by Parallel Advisors

Quarter-by-quarter ownership of Neurogene (NGNE) shares owned by Parallel Advisors from 13F filings

Historical chart of Parallel Advisors investment in Neurogene

Tip: Access up to 7 years of quarterly data

All positions including Neurogene held by Parallel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurogene by Parallel Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.9k 96 20.16

More positions owned by Parallel Advisors

Ishares S&p 500 Index Etf (IVV)
Apple Stock (AAPL)
Nvidia Corp Stock (NVDA)
Ishares Core S&p Total U.s. Stock Market Etf Etf (ITOT)
Corcept Therapeutics Stock (CORT)
Ishares U.s. Equity Factor Rotation Active Etf Etf (DYNF)
Microsoft Stock (MSFT)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Google Stock (GOOGL)
Amazon.com Stock (AMZN)
Avantis International Equity Etf Etf (AVDE)
Cvb Finl Corp Stock (CVBF)
Vanguard Large Cap Etf (VV)
Avantis Emerging Markets Equity Etf Etf (AVEM)
Victoryshares Free Cash Flow Etf Etf (VFLO)

View all positions for Parallel Advisors

Top funds holding Neurogene

Samsara BioCapital
Redmile Group
Casdin Capital
Rtw Investments
EcoR1 Capital
BlackRock
Baker Bros. Advisors
Trails Edge Capital Partners
Balyasny Asset Management
Toronto-Dominion Bank
Vanguard Group
Jennison Associates
Arrowpoint Asset Management
Vanguard Capital Management
Dr. Jeffrey R. Jay, M.D.

View all funds holding Neurogene